These carcinogens induce chronic inflammation, promoting cancer progression through the release of pro-inflammatory cytokines (e.g., TNF, IL-6, IL-8, IL-1β), activation of transcription factors (e.g., NF-κB), and enhancement of angiogenesis [1]. Here, TNF is linked to cancer.